NEW YORK, Oct 26 - Lexicon Genetics on Thursday reported third quarter net losses of $1.5 million, or three cents a share, including stock-based compensation charges for options granted to employees, compared with net losses of $3.8 million, or 10 cents a share, in the year ago period.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.